Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer
Gayle Jameson, Morgan Truitt, Denise J. Roe, Ron Korn et al.
Journal
Redox Biology
Topics
Vitamin C and Antioxidants Research
article
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer
Gayle Jameson, Morgan Truitt, Denise J. Roe, Ron Korn, Haiyong Han, David Propper, S. Danielle. Legrand, Joshua D. Rabinowitz, Michael S. Gordon, Erkut Borazanci, Michael T. Barrett, Kellen Olszewski, Daniel D. Von Hoff, Max Miller, Ronald M. Evans, Michael Downes, Betsy C. Wertheim
article en
Abstract
No abstract available for this paper.
Publication Tag
Redox BiologyVol. 88
Institutions
Translational Genomics Research Institute (US), Salk Institute for Biological Studies (US), University of Arizona (US), Queen Mary University of London (GB), Princeton University (US), Mayo Clinic in Arizona (US), HonorHealth (US), Ludwig Cancer Research (US), University of Arizona Cancer Center